Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Hsin-Yin Chuang

Hsin-Yin Chuang profile photo picture

Postdoctoral Researcher

Institution: Medical College of Wisconsin
Department: Biomedical Engineering

Publications (7)

  • uPAR-Guided Dendrimer Gel Nanoparticles Reprogram Inflammation to Stabilize Atherosclerotic Plaques. (Chuang HY, Kou H, Huang YW, Yang H) ACS Appl Mater Interfaces 2026 Jul 08;18(26):36455-36469 PMID: 42340987 PMCID: PMC13352503 SCOPUS ID: 2-s2.0-105044248260 06/24/2026    
  • NeuProIO: A dual-Action Solid Drug Nanoparticle Topical Formulation for Simultaneous Intraocular Pressure Reduction and Neuroprotection for Glaucoma. (Xu L, Li M, Qi L, Wang TC, Liu D, Mani VJ, Chuang HY, Yang Q, Mu R, Mahdi S, Huang D, Shi H, Hu Y, Yang H) Chem Eng J 2026 Feb 15;530 PMID: 41726861 PMCID: PMC12919395 SCOPUS ID: 2-s2.0-105029233905 02/23/2026       2 Citations
  • Dendrimer Gel Nanoparticles with Dual-Targeting of uPAR and Ribonucleotide Reductase R2 Influence Necrosis, Apoptosis, and Cell Cycle Arrest in Triple-Negative Breast Cancer. (Chuang HY, Huang YW, Yang H) Mol Pharm 2025 Dec 01;22(12):7620-7629 PMID: 41217876 PMCID: PMC12684374 SCOPUS ID: 2-s2.0-105023390923 11/11/2025       2 Citations
  • Evaluating the Toxicity of Electronic Cigarette Aerosols for Firsthand and Secondhand Exposure Under Different Device Operating Conditions. (Kapiamba KF, Chuang HY, Hao W, Lin TC, Chen LC, Huang YW, Wang Y) Chem Res Toxicol 2025 Aug 18;38(8):1344-1356 PMID: 40771151 SCOPUS ID: 2-s2.0-105013761027 08/07/2025       2 Citations
  • Highly Adaptable Dendrimer Gel Nanoparticles with Dual Targeting of uPAR and Ribonucleotide Reductase R2 for Better Retention and Improved Therapeutic Outcomes in Triple-Negative Breast Cancer. (Chuang HY, Huang D, Qi L, Singh V, Chernatynskaya A, Huang YW, Yang H) ACS Appl Mater Interfaces 2025 Jun 11;17(23):33439-33450 PMID: 40456699 PMCID: PMC12700075 SCOPUS ID: 2-s2.0-105007512700 06/03/2025       6 Citations
  • Liposomes-Encapsulating Double-Stranded Nucleic Acid (Poly I:C) for Head and Neck Cancer Treatment. (Singh V, Chernatynskaya A, Qi L, Chuang HY, Cole T, Jeyalatha VM, Bhargava L, Yeudall WA, Farkas L, Yang H) ACS Pharmacol Transl Sci 2024 May 10;7(5):1612-1623 PMID: 38751634 PMCID: PMC11092114 SCOPUS ID: 2-s2.0-85190870664 05/16/2024       12 Citations
  • Secreted Neutrophil Gelatinase-Associated Lipocalin Shows Stronger Ability to Inhibit Cyst Enlargement of ADPKD Cells Compared with Nonsecreted Form. (Chuang HY, Jeng WY, Wang E, Jiang ST, Hsu CM, Hsieh-Li HM, Chiou YY) Cells 2022 Jan 30;11(3) PMID: 35159293 PMCID: PMC8834617 SCOPUS ID: 2-s2.0-85123599442 02/16/2022       5 Citations
    • Last update: 09/14/2026